Get the Stockscreener App
0.894
3.82%
0.0329
After Hours:
.90
0.006
+0.67%
Microbot Medical Inc stock is traded at $0.894, with a volume of 166.65K.
It is up +3.82% in the last 24 hours and up +1.59% over the past month.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
See More
Previous Close:
$0.8611
Open:
$0.91
24h Volume:
166.65K
Relative Volume:
1.09
Market Cap:
$14.59M
Revenue:
-
Net Income/Loss:
$-10.58M
P/E Ratio:
-0.6041
EPS:
-1.48
Net Cash Flow:
$-9.21M
1W Performance:
+5.18%
1M Performance:
+1.59%
6M Performance:
-27.32%
1Y Performance:
-35.68%
1-Day Range:
$0.8701
$0.91
1-Week Range:
$0.85
$0.91
52-Week Range:
$0.82
$2.3499
Microbot Medical Inc Stock (MBOT) Company Profile
Name
Microbot Medical Inc
Sector
Industry
Phone
908-938-5561
Address
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-24-19 | Reiterated | H.C. Wainwright | Buy |
| Jan-31-18 | Initiated | Ladenburg Thalmann | Buy |
Microbot Medical Inc Stock (MBOT) Latest News
Microbot Medical Nears FDA Submission with Clinical Advances - TipRanks
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to - The Bakersfield Californian
Microbot Medical Accelerates Patient Enrollment of its - GlobeNewswire
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up - StockTitan
Epoch Investment Partners Inc. Decreases Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
MicroAlgo receives Nasdaq minimum bid price warning - Investing.com
MicroAlgo Faces Nasdaq Minimum Price Warning - TipRanks
MLGO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Quarterly Snapshot: Quick and Current Ratios for MicroAlgo Inc (MLGO) - The Dwinnex
The Wild Robot giveaway - Lyles Movie Files
Pedro Pascal and Lupita Nyong’o starrer The Wild Robot to release in Indian theatres on October 18 - Bollywood Hungama
Win Advance Screening Passes to THE WILD ROBOT in Florida - FlickDirect, Your Premiere Source For Movies And Entertainment!
Creo Medical Partners with Micro-Tech for Strategic Growth - TipRanks
Microbot Medical (NASDAQ:MBOT) & Treace Medical Concepts (NASDAQ:TMCI) Head-To-Head Review - Defense World
OrbiMed executives purchase $12 million of MBX Biosciences stock By Investing.com - Investing.com UK
The Wild Robot- Chicago – Advance Screening - The Movie Blog
Microbot Medical Advances in Endovascular Robotic Trials - TipRanks
Microbot Medical Announces the Successful Enrollment of 50% - GlobeNewswire
Microbot Medical Inc. Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System - Marketscreener.com
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System - StockTitan
Microbot Medical Stock Is Moving Higher: What's Going On? - MSN
Microbot Medical Shares Investor Presentation Update - TipRanks
MBOT stock touches 52-week low at $0.85 amid market challenges - Investing.com
MBOT stock touches 52-week low at $0.85 amid market challenges - Investing.com UK
Market Resilience: Microbot Medical Inc (MBOT) Finishes Weak at 0.88, Down -4.35 - The Dwinnex
Microbot Medical, Emory University To Consider LIBERTY Robotic System Partnership - MPO-mag
Microbot Medical advances Liberty Robotic System telesurgery innovation - Yahoo Finance
Microbot Medical advances Liberty Robotic System telesurgery innovation - Medical Device Network
Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY - MSN
Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY - Yahoo Finance
Microbot advances Liberty robotic system to next phase of remote telesurgery evaluation - Medical Device Network
Microbot Medical advances telesurgery with new phase - Investing.com India
Microbot Medical advances telesurgery with new phase By Investing.com - Investing.com Canada
Examining MBOT’s book value per share for the latest quarter - US Post News
Microbot Medical advances telesurgery with new phase By Investing.com - Investing.com Australia
Microbot Medical Advances Telesurgery with Corewell Health Collaboration - TipRanks
Microbot Medical advances telesurgery with new phase - Investing.com
Microbot Medical advances telesurgery with new phase By Investing.com - Investing.com UK
Microbot Medical Signs Phase 2 Collaboration Agreement with - GlobeNewswire
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System - ForexTV.com
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System - StockTitan
MBOT Stock Earnings: Microbot Medical Meets EPS for Q2 2024 - MSN
Microbot Medical (FRA:CY9D) 3-Year EPS without NRI Growth R - GuruFocus.com
MBOT (Microbot Medical) Market Cap : $16.45 Mil (As of Aug. 19, 2024) - GuruFocus.com
Microbot Medical (FRA:CY9D) Owner Earnings per Share (TTM) : -0.62 (As of Jun. 2024) - GuruFocus.com
Microbot Medical (FRA:CY9D) 6-1 Month Momentum % : -15.68% (As of Aug. 19, 2024) - GuruFocus.com
Microbot Medical (FRA:CY9D) 9-Day RSI : 51.16 (As of Aug. 19, 2024) - GuruFocus.com
Microbot Medical (MBOT) Gets Quality Certification for its System - Yahoo Finance
Microbot Medical (MBOT) Gets Quality Certification for its System - Zacks Investment Research
MBOT (Microbot Medical) EV-to-Revenue : (As of Aug. 19, 2024) - GuruFocus.com
Microbot Medical (FRA:CY9D) EPS without NRI : €-0.82 (TTM As of Mar. 2024) - GuruFocus.com
Microbot Medical Inc Stock (MBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):